Inclusion Criteria:  Age > 18 years Hair type 3 (curly) or type 4 (kinky) Diagnosis of breast or non-small cell lung cancer (NSCLC) stage I-III  Patient will be starting >4 cycles of taxane-based chemotherapy treatment for curative intent after enrollment  a. Concurrent HER, cisplatin, and cyclophosphamide therapies allowed  Eastern Cooperative Oncology Group (ECOG) 0-2: fully active, restrictive in physically strenuous activity, ambulatory and capable of self-care  Exclusion Criteria:  Hair type other than 3 or 4 Use of hair weave or extensions without plans to remove Diagnosis of breast cancer or NSCLC stage IV Concurrent malignancy including hematologic malignancies (i.e. leukemia or lymphoma) Alopecia Common Terminology Criteria for Adverse Events > grade 1 at baseline Past chemotherapy administration or administration of anthracyclines (doxorubicin) History of migraines or cluster headaches, anorexia, severe anemia, uncontrolled diabetes, hepatitis, thyroid dysfunction, cold urticaria, cold agglutinin disease, scalp metastases Planned bone marrow ablation chemotherapy or skull irradiation